The use of polymers and polymeric structures in the treatment, diagnosis, and monitoring of biological systems is continuing to increase in sophistication. Research exploring the use of nanoparticles for drug delivery applications has included the exploration and development of nanocolloids, liposomes, micelles, nanogels, polymer‐drug conjugates, and a variety of other polymeric nanoparticles that are composed of organic polymers with specific physical or chemical properties that make them relevant delivery vehicles. One of the current trends is the fabrication of tunable, mono‐dispersed, polymeric nanostructures to be used as nanoparticle drug delivery platforms. The PRINT technology used to fabricate monodisperse particles from a wide range of particle matrix materials including biocompatible poly(ethylene glycol) and bioabsorbable poly(d‐lactic acid) is described along with an abbreviated overview of other polymeric drug delivery platforms.
No takes yet. Share an insight, caveat, or question.
Napier et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: